285 related articles for article (PubMed ID: 9799653)
1. Targeted overexpression of phospholamban to mouse atrium depresses Ca2+ transport and contractility.
Neumann J; Boknik P; DePaoli-Roach AA; Field LJ; Rockman HA; Kobayashi YM; Kelley JS; Jones LR
J Mol Cell Cardiol; 1998 Oct; 30(10):1991-2002. PubMed ID: 9799653
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the Na(+)-Ca2+ exchanger leads to enhanced inotropic responsiveness to Na(+)-channel agonist without sarcoplasmic reticulum protein changes in transgenic mice.
Bäumer AT; Flesch M; Kilter H; Philipson KD; Böhm M
Biochem Biophys Res Commun; 1998 Aug; 249(3):786-90. PubMed ID: 9731214
[TBL] [Abstract][Full Text] [Related]
3. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.
Kadambi VJ; Ponniah S; Harrer JM; Hoit BD; Dorn GW; Walsh RA; Kranias EG
J Clin Invest; 1996 Jan; 97(2):533-9. PubMed ID: 8567978
[TBL] [Abstract][Full Text] [Related]
4. Expression of cardiac calcium regulatory proteins in atrium v ventricle in different species.
Lüss I; Boknik P; Jones LR; Kirchhefer U; Knapp J; Linck B; Lüss H; Meissner A; Müller FU; Schmitz W; Vahlensieck U; Neumann J
J Mol Cell Cardiol; 1999 Jun; 31(6):1299-314. PubMed ID: 10371704
[TBL] [Abstract][Full Text] [Related]
5. Enhanced myocardial relaxation in vivo in transgenic mice overexpressing the beta2-adrenergic receptor is associated with reduced phospholamban protein.
Rockman HA; Hamilton RA; Jones LR; Milano CA; Mao L; Lefkowitz RJ
J Clin Invest; 1996 Apr; 97(7):1618-23. PubMed ID: 8601626
[TBL] [Abstract][Full Text] [Related]
6. Cardiac-specific overexpression of sarcolipin in phospholamban null mice impairs myocyte function that is restored by phosphorylation.
Gramolini AO; Trivieri MG; Oudit GY; Kislinger T; Li W; Patel MM; Emili A; Kranias EG; Backx PH; Maclennan DH
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2446-51. PubMed ID: 16461894
[TBL] [Abstract][Full Text] [Related]
7. The effect of isoproterenol on phospholamban-deficient mouse hearts with altered thyroid conditions.
Brittsan AG; Kiss E; Edes I; Grupp IL; Grupp G; Kranias EG
J Mol Cell Cardiol; 1999 Sep; 31(9):1725-37. PubMed ID: 10471356
[TBL] [Abstract][Full Text] [Related]
8. Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium.
Dash R; Frank KF; Carr AN; Moravec CS; Kranias EG
J Mol Cell Cardiol; 2001 Jul; 33(7):1345-53. PubMed ID: 11437540
[TBL] [Abstract][Full Text] [Related]
9. Functional properties of transgenic mouse hearts overexpressing both calsequestrin and the Na(+)-Ca(2+) exchanger.
Linck B; Bokník P; Huke S; Kirchhefer U; Knapp J; Lüss H; Müller FU; Neumann J; Tanriseven Z; Vahlensieck U; Baba HA; Jones LR; Philipson KD; Schmitz W
J Pharmacol Exp Ther; 2000 Aug; 294(2):648-57. PubMed ID: 10900244
[TBL] [Abstract][Full Text] [Related]
10. Phospholamban modulates murine atrial contractile parameters and responses to beta-adrenergic agonists.
Kadambi VJ; Koss KL; Grupp IL; Kranias EG
J Mol Cell Cardiol; 1998 Jul; 30(7):1275-84. PubMed ID: 9710796
[TBL] [Abstract][Full Text] [Related]
11. Phospholamban-mediated stimulation of Ca2+ uptake in sarcoplasmic reticulum from normal and failing hearts.
Movsesian MA; Colyer J; Wang JH; Krall J
J Clin Invest; 1990 May; 85(5):1698-702. PubMed ID: 2139670
[TBL] [Abstract][Full Text] [Related]
12. Phospholamban and cardiac contractility.
Frank K; Kranias EG
Ann Med; 2000 Nov; 32(8):572-8. PubMed ID: 11127935
[TBL] [Abstract][Full Text] [Related]
13. Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation.
El-Armouche A; Boknik P; Eschenhagen T; Carrier L; Knaut M; Ravens U; Dobrev D
Circulation; 2006 Aug; 114(7):670-80. PubMed ID: 16894034
[TBL] [Abstract][Full Text] [Related]
14. Sarcoplasmic reticulum Ca2+ refilling controls recovery from Ca2+-induced Ca2+ release refractoriness in heart muscle.
Szentesi P; Pignier C; Egger M; Kranias EG; Niggli E
Circ Res; 2004 Oct; 95(8):807-13. PubMed ID: 15388639
[TBL] [Abstract][Full Text] [Related]
15. Transgenic triadin 1 overexpression alters SR Ca2+ handling and leads to a blunted contractile response to beta-adrenergic agonists.
Kirchhefer U; Jones LR; Begrow F; Boknik P; Hein L; Lohse MJ; Riemann B; Schmitz W; Stypmann J; Neumann J
Cardiovasc Res; 2004 Apr; 62(1):122-34. PubMed ID: 15023559
[TBL] [Abstract][Full Text] [Related]
16. Phospholamban: a crucial regulator of cardiac contractility.
MacLennan DH; Kranias EG
Nat Rev Mol Cell Biol; 2003 Jul; 4(7):566-77. PubMed ID: 12838339
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the kinetic effects of phospholamban phosphorylation and anti-phospholamban monoclonal antibody on the calcium pump in purified cardiac sarcoplasmic reticulum membranes.
Antipenko AY; Spielman AI; Sassaroli M; Kirchberger MA
Biochemistry; 1997 Oct; 36(42):12903-10. PubMed ID: 9335549
[TBL] [Abstract][Full Text] [Related]
18. Relationship between phospholamban and nucleotide activation of cardiac sarcoplasmic reticulum Ca2+ adenosinetriphosphatase.
Coll KE; Johnson RG; McKenna E
Biochemistry; 1999 Feb; 38(8):2444-51. PubMed ID: 10029538
[TBL] [Abstract][Full Text] [Related]
19. Increased cardiomyocyte function and Ca2+ transients in mice during early congestive heart failure.
Mørk HK; Sjaastad I; Sande JB; Periasamy M; Sejersted OM; Louch WE
J Mol Cell Cardiol; 2007 Aug; 43(2):177-86. PubMed ID: 17574269
[TBL] [Abstract][Full Text] [Related]
20. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation.
Luo W; Grupp IL; Harrer J; Ponniah S; Grupp G; Duffy JJ; Doetschman T; Kranias EG
Circ Res; 1994 Sep; 75(3):401-9. PubMed ID: 8062415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
